Topiroxostat Impurity A
|
托匹司他杂质A
|
|
P-TOLUENESULFONIC ACID SEC-BUTYL ESTER
|
对苯磺酸异丁酯(托匹司他)
|
715-11-7
|
4-Chlorobutyryl chloride
|
4-氯丁酰氯
|
4635-59-0
|
Solina New Impurity 8 Control
|
索利那新杂质8对照品
|
|
Dihydroxy oxaliplatin
|
双羟基奥沙利铂
|
|
Azimide Impurity 1
|
阿嗪米特杂质1
|
|
Lesinurad Imp.L
|
|
|
Ranitidine Impurity D
|
雷尼替丁杂质D
|
|
Imatinib Impurity R
|
伊马替尼杂质R
|
|
Tofacitinib impurity V
|
托法替尼杂质V
|
|
Gemcitabine hydrochloride Impurity C
|
盐酸吉西他滨杂质C
|
|
Rivaroxabn Imp.O
|
利伐沙班杂质O
|
|
Vortioxetine Imp.E
|
沃替西汀杂质E
|
508233-77-0
|
1-Hydroxy-2-naphthoic acid
|
1-羟基-2-萘甲酸
|
86-48-6
|
Vortioxetine Imp.X
|
沃替西汀杂质X
|
|
N-Methylcyclohexylamine
|
N-甲基环己胺
|
100-60-7
|
LCZ-696 Impurity 14
|
LCZ696杂质14
|
|
Terazosin EP Impurity I
|
特拉唑嗪EP杂质I
|
1799288-88-2
|
Tofacitinib impurity U
|
托法替尼杂质U
|
|
Sorafenib IMpurity I
|
索拉非尼杂质I
|
|
Avanafil iMpurity 3
|
阿伐那非杂质3
|
|
N-(2,6-dichlorophenyl)-2-phenylacetamide
|
双氯芬酸钠杂质10
|
304884-75-1
|
Apixaban Impurity 27
|
阿哌沙班杂质27
|
2029205-54-5
|
2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid
|
贝尼地平杂质E
|
74936-81-5
|
Risperidone Impurity 1
|
利培酮杂质1
|
66698-27-9
|
Roxatidine acetate (free state)
|
罗沙替丁醋酸酯(游离态)
|
|
Cladribine Impurity A
|
克拉屈滨杂质A
|
|
Levosimendan Impurity 1
|
左西孟旦杂质1
|
1643439-59-1
|
Alogliptin Imp.11
|
阿格列汀杂质11
|
|
Apremilast Impurity C
|
阿普斯特杂质C
|
|
Rivaroxaban Imp.VI oxo phthalimide
|
利伐沙班杂质V
|
|
APST-ZB
|
阿普斯特二聚体
|
253168-87-5
|
Parecoxib Impurity N
|
帕瑞昔布杂质N
|
|
CYCLOSPORIN D
|
环孢霉素杂质D
|
63775-96-2
|
IlaprazoleImpuritySM1-F
|
艾普拉唑杂质SM1-F
|
|
Linagliptin Impurity U
|
利拉利汀杂质U
|
|
Isomannide
|
1,4:3,6-双脱水甘露醇
|
641-74-7
|
Prucalopride IMpurity 8
|
普芦卡必利杂质8
|
|
Canagliflozin Dimer Impurity 2
|
卡格列净二聚体杂质2
|
|
Ketorolac Impurity 29
|
酮咯酸杂质29
|
|
Canagliflozin Impurity 16
|
卡格列净杂质16
|
|
OlanzapineImpurity(ADP-2c)
|
奥氮平杂质(ADP-2c)
|
|
LenvatinibImpurity
|
乐伐替尼杂质K
|
|
Alogliptin benzoate
|
阿格列汀API
|
850649-62-6
|
Lacosamide impurity H
|
拉科酰胺杂质H
|
|
Lenatinib impurity PHA
|
来那替尼杂质PHA
|
|
Amoxicillin Impurity X (mixture of diastereomers)
|
阿莫西林杂质X(非对映异构体混合物)
|
|
Eltrombopag nitrogen oxide impurities
|
艾曲波帕氮氧化物杂质
|
|
3-Phenylpropionic acid
|
3-苯基丙酸
|
501-52-0
|
Dipropylmalonic Acid
|
二丙基丙二酸
|
1636-27-7
|
cefoxitin iMpurity D
|
头孢西丁杂质D
|
|
Azilsartan iMpurity K
|
阿齐沙坦杂质K
|
|
Ellagic acid
|
鞣花酸
|
476-66-4
|
1H-Pyrrole-3-carboxylicacid,4-(2-hydroxyethyl)-(9CI)
|
拉维酸钾杂质D对照品
|
404839-11-8
|
1,3:2,4-Bis(3,4-dimethylobenzylideno) sorbitol
|
成核剂 HX-3
|
135861-56-2
|
Miglinide impurity 1-450mg
|
米格列奈杂质1-450mg
|
|
Paliperidone F4 Raw material impurities 1
|
帕潘立酮F4原料杂质1
|
|
Premastast Impurity 2
|
普仑司特杂质2
|
|
MPEG 550
|
聚乙二醇单甲醚550
|
9004-74-4
|
Hydroxychloroquine sulfate impurity 3 with sodium salt
|
硫酸羟氯喹杂质3带钠盐
|
|
Voronazan Fumarate Starter I Impurity B
|
富马酸沃诺拉赞起始物I杂质B
|
|
Flibanserin nitrogen oxide impurities
|
氟班色林氮氧化物杂质
|
|
Obeticholic acid API
|
奥贝胆酸API
|
|
Warfarin Impurity E
|
华法林杂质E
|
38063-51-3
|
Non-masartan impurity 8
|
非马沙坦杂质8
|
|
Thiopronin Impurity I (2-chloropropionylglycine)
|
硫普罗宁杂质I(2-氯丙酰甘氨酸)
|
|
1-(2,3-dichlorophenyl)aziridine reference substance
|
1-(2,3-二氯苯基)氮丙啶对照品
|
|
Cinacalcet Impurity 41
|
西那卡塞杂质 41
|
191155-81-4
|
Iloperidone Impurity 5
|
伊潘立酮杂质5
|
1487957-15-2
|
Relying on Corcoxi Impurity P0Z11
|
依托考昔杂质P0Z11
|
|
Imatinib beta impurity SM2
|
伊马替尼β型杂质SM2
|
|
Fluoxetine hydrochloride impurity FXT-P
|
盐酸氟西汀杂质FXT-P
|
310452-40-5
|
Vortioxetine impurity 1 [1-(2,4-dimethylphenyl) piperidine
|
沃替西汀杂质1【1-(2,4-二甲基苯基)哌啶】
|
|
Ketorolac tromethamine intermediate 5 Impurity 5
|
酮咯酸氨丁三醇中间体5杂质5
|
|
STMG Ticagrelor Imp.A
|
替格瑞洛杂质STMG Ticagrelor Imp.A
|
|
Tigrelo Deethoxy Impurity
|
替格瑞洛脱乙氧基杂质
|
|
Sofosbuvir related impurities B
|
索非布韦相关杂质B
|
|
Thiazole ring impurity 1
|
噻唑环杂质1
|
|
Regofenib impurity 10221-1225
|
瑞戈非尼杂质10221-1225
|
|
Tragliptin Impurity 10 Control
|
曲格列汀杂质10对照品
|
|
Ketorolac tromethamine intermediate 6 Impurity 2
|
酮咯酸氨丁三醇中间体6杂质2
|
|
Ketorolac tromethamine intermediate 4 Impurity 2
|
酮咯酸氨丁三醇中间体4杂质2
|
|
Voronazan Starter Impurity 6 Control
|
沃诺拉赞起始物杂质6对照品
|
|
DL-2-(2-Chlorophenyl)glycine
|
DL-邻氯苯甘氨酸
|
141196-64-7
|
Vortioxetine Imp.H
|
沃替西汀杂质H
|
|
Vortioxetine Imp.M
|
沃替西汀杂质M
|
|
Trelagliptin Impurity 3
|
曲格列汀杂质 3
|
|
Topiroxostat Imp.G
|
托匹司他杂质G
|
|
Ceritinib Impurity 11
|
色瑞替尼杂质11
|
|
Alogliptin Imp.5
|
阿格列汀杂质5
|
|
L-Orn-L-Asp imputiy 7
|
鸟氨酸-门冬氨酸杂质7
|
|
Hydroxychloroquine Impurity 2
|
羟氯喹杂质2
|
|
Tigrelo Impurity C5EN (tartaric acid)
Ticagrelor Intermediate 1
|
替格瑞洛杂质C5EN(重酒石酸)
Ticagrelor Intermediate 1
|
|
Sofosbuvir Impurity Q
|
索磷布韦杂质Q
|
|
1-PYRIDIN-2-YL-ETHANOL
|
2-(1-羟乙基)吡啶
|
18728-61-5
|
Oxidation of impurities by bromoxine hydrochloride
|
盐酸溴已新氮氧化杂质
|
|
Hydroxychloroquine Impurity 13
|
羟氯喹杂质13
|
|
Ticagrelor Impurity 17
|
替格瑞洛杂质-1-7
|
|
Esomeprazole Impurity
|
埃索美拉唑杂质
|
|
Iloperidone Impurity 18
|
伊潘立酮杂质18
|
|
Lurasidone Impurity HS126205
|
鲁拉西酮杂质HS126205
|
|
Cetirizine Propylene Glycol Impurity Dihydrochloride
|
西替利嗪丙二醇酯杂质二盐酸
|
|
Tedazolamide Chlorinated Impurities
|
泰地唑胺氯代杂质
|
|
Sofosbuvir chlorinated impurities 2
|
索非布韦氯代杂质2
|
|
Diclofenac sodium impurity 4
|
双氯酚酸钠杂质4
|
|
Tandospirone impurity 9
|
坦度螺酮杂质9
|
|
Trazodone Impurity G Hydrochloride
|
曲唑酮杂质G盐酸盐
|
|
Deflucetirizine Impurity
|
去氟西替利嗪杂质
|
|
Hydroxyurea impurity ZQA
|
羟基脲杂质ZQA
|
|